SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000935836-23-000128
Filing Date
2023-02-13
Accepted
2023-02-13 10:13:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 kros13ga.htm SC 13G/A 40644
  Complete submission text file 0000935836-23-000128.txt   42114
Mailing Address 350 MADISON AVENUE 20TH FLOOR NEW YORK NY 10017
Business Address 350 MADISON AVENUE 20TH FLOOR NEW YORK NY 10017 2127166576
ALKEON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001230239 (see all company filings)

IRS No.: 134200093 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Subject) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91484 | Film No.: 23615391
SIC: 2834 Pharmaceutical Preparations